Clinical Implications of KRAS Mutations in Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors: An Important Role for Mutations in Minor Clones

Схожие документы

• Clinical Implications of KRAS Mutations in Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors: An Important Role for Mutations in Minor Clones
  по: Antonio Marchetti, et al.
  Опубликовано: (2009-10-01)
• Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications
  по: Marchetti, Antonio, et al.
  Опубликовано: (2012)
• Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment
  по: Marchetti, Antonio, et al.
  Опубликовано: (2014)
• Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients
  по: Cappuzzo, Federico, et al.
  Опубликовано: (2009)
• Mutational Profile of GNAQ (Q209) in Human Tumors
  по: Lamba, Simona, et al.
  Опубликовано: (2009)